title: Function-blocking antithrombospondin-1 monoclonal antibodies.
abstract: BACKGROUND
  Thrombospondin-1 (TSP-1) has been implicated in many different processes based in part on inhibitory activities of anti-TSP-1 monoclonal antibodies (mAbs).
  
  
  OBJECTIVE
  To map epitopes of 13 anti-TSP-1 mAbs to individual modules or groups of modules spanning TSP-1 and the closely related TSP-2 homolog.
  
  
  RESULTS
  The mapping has led to assignment or reassignment of the epitopes of four mAbs, refinement of the epitopes of six mAbs, and confirmation of the epitopes of the remaining three mAbs. ESTs10, P12, and MA-II map to the N-terminal domain; 5G11, TSP127.6, and ESTs12 to the third properdin module; C6.7, HB8432, and P10 to epidermal growth factor (EGF)-like modules 1 and/or 2; and A6.1, mAb133, MA-I, and D4.6 to the calcium-binding wire module. A6.1, which recognizes a region of the wire that is identical in mouse and human TSP-1, reacts with TSP-1 from both species, and also reacts weakly with human TSP-2. Two other mouse antihuman TSP-1 mAbs, A4.1 and D4.6, also react with mouse TSP-1.
  
  
  CONCLUSIONS
  Consideration of previous literature and mapping of epitopes of inhibitory mAbs suggest that biological activities are present throughout TSP-1, including the EGF-like modules that have not been implicated in the past. Because the epitopes for 10 of the antibodies likely are within 18 nm of one another in calcium-replete TSP-1, some of the inhibitory effects may result from steric hindrance. Such seems to be the case for mAb133, which binds the calcium-binding wire but is still able to interfere with the activation of latent TGF-beta by the properdin modules.
authors.affiliation: Department of Medicine, University of Wisconsin, Madison, WI 53706, USA.
authors.forename: D S
authors.initials: DS
authors.lastname: Annis
authors.forename: J E
authors.initials: JE
authors.lastname: Murphy-Ullrich
authors.forename: D F
authors.initials: DF
authors.lastname: Mosher
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D002417:Cattle; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism; D018604:Epitope Mapping; D006801:Humans; D051379:Mice; D017434:Protein Structure, Tertiary; D051381:Rats; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D019700:Thrombospondin 1 / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D019699:Thrombospondins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D016212:Transforming Growth Factor beta / Q000378:metabolism; D000099262:Thrombospondin 2
chemical_list: D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins; D019700:Thrombospondin 1; D019699:Thrombospondins; D016212:Transforming Growth Factor beta; D000099262:Thrombospondin 2